- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Radiologist takes over at NIBIB
The imaging community had more to cheer May 7 when the NIH announced the appointment of Dr. Roderic I. Pettigrew as the first permanent director of the National Institute of Biomedical Imaging and Bioengineering. Pettigrew's background in radiology and
The imaging community had more to cheer May 7 when the NIH announced the appointment of Dr. Roderic I. Pettigrew as the first permanent director of the National Institute of Biomedical Imaging and Bioengineering. Pettigrew's background in radiology and engineering makes him an ideal candidate for this NIH division, which addresses a wide range of biomedical technologies. Currently the director of Emory University's Center for MR Research, Pettigrew holds a doctorate from the Massachusetts Institute of Technology's department of nuclear engineering in applied radiation physics. He is also the immediate past chair of the diagnostic imaging study section at the Center for Scientific Review at NIH--the section that reviews grant applications to develop and evaluate new imaging technology, including instrumentation and software for producing, evaluating, storing, and transmitting images.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
